Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes

被引:133
作者
Costa, LA
Canani, LH
Lisbôa, HRK
Tres, GS
Gross, JL [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Serv Endocrinol, BR-90046900 Porto Alegre, RS, Brazil
[2] Univ Luterana Brazil, Dept Internal Med, Canoas, Brazil
关键词
metabolic syndrome; Type; 2; diabetes; chronic complications;
D O I
10.1111/j.1464-5491.2004.01124.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To investigate the association of features of the metabolic syndrome with the prevalence of chronic complications. Methods A cross-sectional study was conducted with 548 patients with Type 2 diabetes mellitus (DM). Metabolic syndrome was diagnosed in the presence of at least two of the following: hypertension, dyslipidaemia, obesity, and microalbuminuria. Results Patients with the metabolic syndrome (85%) had a higher prevalence of peripheral vascular disease (PVD) (35% vs. 18%), retinopathy (44% vs. 20%), distal sensory neuropathy (DSN) (44% vs. 24%), micro- and macroalbuminuria (38% vs. 28%) and coronary artery disease (CAD) (53% vs. 36%). The more metabolic syndrome features (none/one, two, three or four), the higher the proportion of diabetes complications: PVD 18%, 31%, 37% and 38%; stroke 1.0%, 4.5%, 5.9% and 11.3%; retinopathy 20%, 38%, 42% and 64%; DSN 24%, 32%, 49% and 57%; micro- and macroalbuminuria 28%, 36% and 41%; and CAD 36%, 44%, 52% and 60% (P < 0.05). Conclusions The metabolic syndrome and the aggregation of its components were significantly associated with macro- and microvascular complications in Type 2 DM patients.
引用
收藏
页码:252 / 255
页数:4
相关论文
共 19 条
  • [1] Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients
    Beck, MO
    Silveiro, SP
    Friedman, R
    Clausell, N
    Gross, JL
    [J]. DIABETES CARE, 1999, 22 (10) : 1745 - 1747
  • [2] Prevalence of insulin resistance in metabolic disorders - The Bruneck Study
    Bonora, E
    Kiechl, S
    Willeit, J
    Oberhollenzer, F
    Egger, G
    Targher, G
    Alberiche, M
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES, 1998, 47 (10) : 1643 - 1649
  • [3] Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy
    Canani, LH
    Gerchman, F
    Gross, JL
    [J]. DIABETES CARE, 1998, 21 (09) : 1545 - 1550
  • [4] INSULIN-RESISTANCE, HYPERTENSION AND MICROALBUMINURIA IN PATIENTS WITH TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
    GROOP, L
    EKSTRAND, A
    FORSBLOM, C
    WIDEN, E
    GROOP, PH
    TEPPO, AM
    ERIKSSON, J
    [J]. DIABETOLOGIA, 1993, 36 (07) : 642 - 647
  • [5] Hodge AM, 1996, DIABETIC MED, V13, P441
  • [6] Cardiovascular morbidity and mortality associated with the metabolic syndrome
    Isomaa, B
    Almgren, P
    Tuomi, T
    Forsén, B
    Lahti, K
    Nissén, M
    Taskinen, MR
    Groop, L
    [J]. DIABETES CARE, 2001, 24 (04) : 683 - 689
  • [7] The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes
    Isomaa, B
    Henricsson, M
    Almgren, P
    Tuomi, T
    Taskinen, MR
    Groop, L
    [J]. DIABETOLOGIA, 2001, 44 (09) : 1148 - 1154
  • [8] Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn study
    Jager, A
    Kostense, PJ
    Nijpels, G
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    [J]. DIABETOLOGIA, 1998, 41 (06) : 694 - 700
  • [9] Insulin resistance - Does it play a role in peripheral neuropathy?
    Lee, RH
    Dellon, AL
    [J]. DIABETES CARE, 1999, 22 (11) : 1914 - 1915
  • [10] ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients
    Lee, YJ
    Tsai, JCR
    [J]. DIABETES CARE, 2002, 25 (06) : 1002 - 1008